161.
Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis
by Xian, Guozhe
Cancer letters, 2016, Vol.385, p.65-74
162.
Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)
by Bang, Casper N., MD, PhD
The American journal of cardiology, 2015, Vol.116 (12), p.1840-1844
163.
Genetic and Pharmacological Modulation of Akt1 for Improving Ovarian Graft Revascularization in a Mouse Model
by Cohen, Yoni
Biology of reproduction, 2016, Vol.94 (1), p.14-14
164.
Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia
by Milionis, Haralampos J
The American heart journal, 2004, Vol.148 (4), p.635-640
165.
Simvastatin Treatment Upregulates Anti-Fibrotic Bone Morphogenetic Protein-7 Expression at Rat Cardiac Allograft Rejection
by Holmström, Emil J
Pharmacology, 2016, Vol.98 (5-6), p.204-208
166.
Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Po...
by Cao, Xiting, PhD
Clinical therapeutics, 2015, Vol.37 (4), p.804-815
167.
Statins for sepsis: a critical and updated review
by Kopterides, P
Clinical microbiology and infection, 2009, Vol.15 (4), p.325-334
168.
Influence of Simvastatin as Augmentative Therapy in the Treatment of Generalized Anxiety Disorder: A Pilot Randomized, Placebo-Controlled Study
by Mirzaei, Ehsan
Neuropsychobiology, 2021, Vol.80 (3), p.242-252
169.
Metabolomic analysis of simvastatin and fenofibrate intervention in high-lipid diet-induced hyperlipidemia rats
by Xu, Qiu-yu
Acta pharmacologica Sinica, 2014, Vol.35 (10), p.1265-1273
170.
Comparisons of effects of statins ( atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart di...
by Schaefer, Ernst J
The American journal of cardiology, 2004, Vol.93 (1), p.31-39
171.
Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma
by Menzies, Daniel, MBChB
Journal of allergy and clinical immunology, 2007, Vol.119 (2), p.328-335
172.
Effect of Simvastatin and Fenofibrate on Cytokine Release and Systemic Inflammation in Type 2 Diabetes Mellitus With Mixed Dyslipidemia
by Krysiak, Robert, MD, PhD
The American journal of cardiology, 2011, Vol.107 (7), p.1010-1018.e1
173.
Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia
by Ballantyne, Christie M
The American journal of cardiology, 2004, Vol.93 (12), p.1487-1494
174.
Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial
by Yusuf, S
The Lancet (British edition), 2009, Vol.373 (9672), p.1341-1351
175.
A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin and simvastatin
by Rogers, Sophie L., MEpi
Clinical therapeutics, 2007, Vol.29 (2), p.242-252
176.
SIMVASTATIN ATTENUATES MICROGLIAL CELLS AND ASTROCYTE ACTIVATION AND DECREASES INTERLEUKIN-1B LEVEL AFTER TRAUMATIC BRAIN INJURY
by Li, Bo
Neurosurgery, 2009, Vol.65 (1), p.179-186
177.
Electronic medical records can be used to emulate target trials of sustained treatment strategies
by Danaei, Goodarz
Journal of clinical epidemiology, 2018, Vol.96, p.12-22
178.
Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients
by Derosa, Giuseppe
Current medical research and opinion, 2009, Vol.25 (8), p.1973-1983
179.
Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositis
by Sancricca, Cristina
Neurological sciences, 2011, Vol.32 (5), p.841-847
180.
Statin therapy in heart failure: is it time for a second look?
by Javaheri, Ali
Hypertension (Dallas, Tex. 1979), 2014, Vol.63 (5), p.909-910
